Fenofibrate-tablet-1 (Fenofibrate Tablets 54 mg And 160 mg 0115 1)
Fenofibrate Tablet
Product Images NDC 0115-5522
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 0115-5522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
50 mg 90 Ct (Fenofibrate Tablets 54 mg And 160 mg 0115 2)
This is a fenofibrate tablet with a usual dosage of 54 mg. The complete prescribing information is available in the accompanying outsert. It should be kept in a tightly-closed, light-resistant container, and stored at a temperature between 20°C to 25°C. The medication should be kept away from the reach of children. The manufacturer of the medication is Amneal Pharmaceuticals LLC, located in Bridgewater, NJ. Lot number, expiry date, and serialization information can be found in a non-varnish area.*
1 (Fenofibrate Tablets 54 mg And 160 mg 0115 3)
This is a medication called Fenofibrate, that is available in tablet form containing 160 mg of fenofibrate. The usual dosage information is available in the accompanying outsert. It should be stored at room temperature and in a tightly-closed, light-resistant container as defined in the USP with a child-resistant closure. There is a printed safety seal under the cap of the container, which should not be used if broken or missing. This medication is distributed by Amneal Pharmaceuticals LLC from Bridgewater, NJ.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
